Skip to main content
. 2021 Apr 9;16:2735–2749. doi: 10.2147/IJN.S298093

Figure 9.

Figure 9

Anti-tumor efficacy of DTX formulations in MCF-7 tumor-bearing nude mice. (A) Tumor growth curve of mice administrated every three days for four times via tail vein. (B) The weight of the excised tumors from all groups. **p<0.01 and *p<0.05. (C) The images of excised tumor, scale bar 1cm. (D) Changes in body weight of tumor-bearing nude mice in each group during anti-tumor efficacy study. Data are expressed as mean ± SD (n= 6). ***p<0.001, vs saline; Δp<0.001, vs DJ(MTD); p<0.01, vs DPM (1/2MTD).